Latest filing published 27 Feb 2026 for INOVIO PHARMACEUTICALS, INC..
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
All filings by Jacqueline Elizabeth Shea on record concern Inovio Pharmaceuticals, Inc., in the capacity of senior executive. The record holds 51 filings, for trades running from 25 March 2020 to 26 February 2026.
No open-market purchase appears, only 8 sales worth €1.3M. The rest of the record consists of 20 share grants and 23 option exercises.
The record was last updated on 27 February 2026 with an option exercise in Inovio Pharmaceuticals, Inc. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
14 of 14 declarations